Research and Development

Research and Development

Shaping the
future of medicine
Start »
Grants 4 Targets

Bayer HealthCare Pharmaceuticals allocates grants for collaboration projects on the further development of promising novel molecular targets in the fields of:

- Oncology - Cardiology

- Gynecology - In vivo Imaging

Do you have innovative ideas! Click here to learn more
From molecules to medicine

The labtour offers a journey through the world of research at Bayer HealthCare Pharmaceuticals. Take an interactive tour from "Target Discovery" to "Approval". more
Oncology

Combining passion with purpose
The vision of the oncology research at Bayer HealthCare Pharmaceuticals is to improve the lives of those affected by cancer. Wtih both our own research and development efforts as well as cooperations we work on the worldwide allocation of treatment options across the globe. more
Closing in on cancer

Cancer is a leading cause of death worldwide, killing 7.6 million people in 2008.
With this interactive tool you can close in on cancer. Discover the transparent virtual person. Learn more about different cancers and existing therapies, the role played by biomarkers or the innovative approaches of the scientists in the fight against cancer. more

News
Facts & Figures
Development Pipeline
Clinical studies

News

05/15/13, Research and Development Bayer Initiates Phase III Trial of Regorafenib in Patients with Advanced Liver Cancer more

04/10/13, Research and Development Bayer HealthCare to broaden strategic alliance with German Cancer Research Center Joint immunotherapy research laboratory at the National Center for Tumor Diseases (NCT) in Heidelberg / Operations at the joint laboratory scheduled to start in the middle of 2013 / Additional investments of up to €3 million per year more

At a glance

Research expenses 2012	EUR 1,556 million
In percent of division sales 2012	14,5%
Employees in Research & Development	7,500 (as of Dec 31, 2012)
Main research sites	Berlin and Wuppertal, Germany and Berkeley, USA
Research focus	Berlin: Imaging techniques, oncology, women's healthcare Wuppertal: Cardiology, oncology Berkeley: Applied research and life cycle management in hemophilia and multiple sclerosis

Promising pipeline ensures mid- and long-term innovation

Bayer HealthCare Pharmaceuticals concentrates its R&D activities on innovative treatment alternatives for diseases with a high unmet medical need to improve patients’ quality of life and prolong lives. The focus is on therapeutic areas with a high medical need, where more innovations are needed despite considerable progress.

We hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology.
more

About Clinical Trials

Clinical trials are used to evaluate potential treatments that have had some effect against disease in the lab, or in animal experiments. The whole point of a clinical trial is to find out if a treatment is effective.

Until sufficient results are available from many different trials it is just that, potential. Effectiveness of a treatment should never be at the expense of safety; the benefit of a treatment should always outweigh the harm and is fundamental to the conduct of all clinical trials.
more